A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Single-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB054 in Healthy Subjects and Subjects with Early Parkinson's Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Biogen Idec Inc.
Start Date
January 19, 2017
End Date
February 27, 2019
Administered By
Neurology, Movement Disorders
Awarded By
Biogen Idec Inc.
Start Date
January 19, 2017
End Date
February 27, 2019